Tarsus Pharmaceuticals (TARS) Competitors $52.91 +0.91 (+1.75%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TARS vs. RVMD, LNTH, NUVL, LEGN, BPMC, ELAN, CYTK, TGTX, VKTX, and BBIOShould you be buying Tarsus Pharmaceuticals stock or one of its competitors? The main competitors of Tarsus Pharmaceuticals include Revolution Medicines (RVMD), Lantheus (LNTH), Nuvalent (NUVL), Legend Biotech (LEGN), Blueprint Medicines (BPMC), Elanco Animal Health (ELAN), Cytokinetics (CYTK), TG Therapeutics (TGTX), Viking Therapeutics (VKTX), and BridgeBio Pharma (BBIO). These companies are all part of the "pharmaceutical products" industry. Tarsus Pharmaceuticals vs. Revolution Medicines Lantheus Nuvalent Legend Biotech Blueprint Medicines Elanco Animal Health Cytokinetics TG Therapeutics Viking Therapeutics BridgeBio Pharma Revolution Medicines (NASDAQ:RVMD) and Tarsus Pharmaceuticals (NASDAQ:TARS) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability. Which has higher valuation and earnings, RVMD or TARS? Tarsus Pharmaceuticals has higher revenue and earnings than Revolution Medicines. Tarsus Pharmaceuticals is trading at a lower price-to-earnings ratio than Revolution Medicines, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRevolution Medicines$742K9,988.85-$436.37M-$3.59-12.27Tarsus Pharmaceuticals$129.62M15.60-$135.89M-$3.81-13.89 Does the MarketBeat Community favor RVMD or TARS? Revolution Medicines received 45 more outperform votes than Tarsus Pharmaceuticals when rated by MarketBeat users. Likewise, 75.63% of users gave Revolution Medicines an outperform vote while only 65.22% of users gave Tarsus Pharmaceuticals an outperform vote. CompanyUnderperformOutperformRevolution MedicinesOutperform Votes9075.63% Underperform Votes2924.37% Tarsus PharmaceuticalsOutperform Votes4565.22% Underperform Votes2434.78% Do institutionals and insiders believe in RVMD or TARS? 94.3% of Revolution Medicines shares are held by institutional investors. Comparatively, 90.0% of Tarsus Pharmaceuticals shares are held by institutional investors. 8.0% of Revolution Medicines shares are held by insiders. Comparatively, 8.3% of Tarsus Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, RVMD or TARS? Revolution Medicines has a beta of 1.4, suggesting that its stock price is 40% more volatile than the S&P 500. Comparatively, Tarsus Pharmaceuticals has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Does the media prefer RVMD or TARS? In the previous week, Revolution Medicines had 8 more articles in the media than Tarsus Pharmaceuticals. MarketBeat recorded 12 mentions for Revolution Medicines and 4 mentions for Tarsus Pharmaceuticals. Revolution Medicines' average media sentiment score of 0.62 beat Tarsus Pharmaceuticals' score of 0.54 indicating that Revolution Medicines is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Revolution Medicines 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tarsus Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is RVMD or TARS more profitable? Revolution Medicines has a net margin of 0.00% compared to Tarsus Pharmaceuticals' net margin of -103.64%. Revolution Medicines' return on equity of -33.67% beat Tarsus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Revolution MedicinesN/A -33.67% -30.08% Tarsus Pharmaceuticals -103.64%-55.86%-39.28% Do analysts prefer RVMD or TARS? Revolution Medicines presently has a consensus target price of $65.82, indicating a potential upside of 49.38%. Tarsus Pharmaceuticals has a consensus target price of $54.20, indicating a potential upside of 2.44%. Given Revolution Medicines' stronger consensus rating and higher possible upside, analysts plainly believe Revolution Medicines is more favorable than Tarsus Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Revolution Medicines 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09Tarsus Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 SummaryRevolution Medicines beats Tarsus Pharmaceuticals on 15 of the 18 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get Tarsus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TARS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TARS vs. The Competition Export to ExcelMetricTarsus PharmaceuticalsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.02B$2.94B$5.12B$9.07BDividend YieldN/A1.90%4.91%4.22%P/E Ratio-13.8946.7391.3417.19Price / Sales15.60411.851,116.59116.80Price / CashN/A182.1042.6437.86Price / Book8.893.894.794.78Net Income-$135.89M-$42.21M$120.07M$225.60M7 Day Performance0.78%-2.14%-1.89%-1.24%1 Month Performance14.03%4.21%11.45%3.36%1 Year Performance163.23%18.40%30.61%16.58% Tarsus Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TARSTarsus Pharmaceuticals0.3267 of 5 stars$52.91+1.8%$54.20+2.4%+164.4%$2.02B$129.62M-13.8950Positive NewsRVMDRevolution Medicines4.5467 of 5 stars$44.77-0.5%$63.67+42.2%+71.5%$7.53B$11.58M-12.54443Insider TradeLNTHLantheus4.3768 of 5 stars$94.38+1.5%$130.00+37.7%+53.4%$6.56B$1.50B15.42834Analyst ForecastNUVLNuvalent2.1736 of 5 stars$86.53-0.4%$112.60+30.1%+16.9%$6.15BN/A-25.0340Insider TradeNews CoveragePositive NewsLEGNLegend Biotech1.553 of 5 stars$33.61-4.3%$81.54+142.6%-43.2%$6.14B$520.18M-36.971,800BPMCBlueprint Medicines2.5942 of 5 stars$95.23+2.2%$122.11+28.2%+7.2%$6.05B$434.42M-45.28640Insider TradeELANElanco Animal Health3.7675 of 5 stars$12.20+0.8%$16.75+37.3%-17.0%$6.03B$4.45B30.259,300CYTKCytokinetics4.1299 of 5 stars$49.22+1.2%$83.93+70.5%+36.8%$5.81B$3.22M-9.04250Analyst ForecastTGTXTG Therapeutics4.3117 of 5 stars$34.81+8.7%$40.67+16.8%+87.1%$5.42B$233.66M-320.17290Positive NewsVKTXViking Therapeutics4.2928 of 5 stars$48.02+2.1%$106.75+122.3%+139.8%$5.35BN/A-51.5620Analyst ForecastGap UpBBIOBridgeBio Pharma4.6924 of 5 stars$27.67+0.7%$47.69+72.4%-30.7%$5.23B$217.77M-11.63400Positive News Related Companies and Tools Related Companies Revolution Medicines Alternatives Lantheus Alternatives Nuvalent Alternatives Legend Biotech Alternatives Blueprint Medicines Alternatives Elanco Animal Health Alternatives Cytokinetics Alternatives TG Therapeutics Alternatives Viking Therapeutics Alternatives BridgeBio Pharma Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TARS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tarsus Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tarsus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
